pyrroles has been researched along with Sicca Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komai, E; Takemoto, M; Yokote, K | 1 |
| Borda, E; Passafaro, D; Reina, S; Sterin-Borda, L | 1 |
2 other study(ies) available for pyrroles and Sicca Syndrome
| Article | Year |
|---|---|
Atorvastatin-induced dermatomyositis in a 47-year-old woman with Sjögren's syndrome.
Topics: Anticholesteremic Agents; Atorvastatin; Dermatomyositis; Female; Heptanoic Acids; Humans; Hyperlipidemias; Middle Aged; Pyrroles; Sjogren's Syndrome | 2015 |
Atorvastatin inhibits the inflammatory response caused by anti-M(3) peptide IgG in patients with primary Sjögren's syndrome.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Autoantibodies; Dinoprostone; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Heptanoic Acids; Humans; Immunoglobulin G; In Vitro Techniques; Interleukin-1beta; Male; Matrix Metalloproteinase 3; Middle Aged; Peptide Fragments; Pyrroles; Rats; Receptor, Muscarinic M3; Sjogren's Syndrome; Submandibular Gland | 2012 |